We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| argenx SE | NASDAQ:ARGX | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -7.92 | -2.07% | 374.63 | 356.94 | 391.14 |
| High Price | Low Price | Open Price | Traded | Last Trade |
|---|---|---|---|---|
| 386.70 | 370.60 | 382.81 | 369,022 | 01:00:00 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/12/2023 | 17:37 | DJN | Argenx Down Nearly 26%, on Pace for Record Percent Decrease -- Data Talk |
| 28/11/2023 | 16:16 | DJN | Argenx Down Over 10%, On Track for Largest Percent Decrease Since May 2022.. |
| 28/11/2023 | 12:03 | DJN | Argenx Shares Down After Vyvgart Study Misses Primary Endpoint |
| 17/7/2023 | 21:58 | DJN | Argenx Launches $750 Million Global Offering |
| 17/7/2023 | 16:59 | DJN | Argenx Up Over 30%, on Track for Record High Close -- Data Talk |
| 17/7/2023 | 16:04 | DJN | Argenx Shares Hit 52-Week High After Positive Vyvgart Hytrulo Trial Results |
| 17/7/2023 | 12:10 | DJN | Argenx, Zai Lab Shares Rise After Positive Trial Results for Vyvgart.. |
| 21/6/2023 | 00:09 | DJN | Argenx Says FDA Approves Vyvgart Hytrulo Injection to Treat Neuromuscular.. |
1 Year argenx Chart |
Intraday argenx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
